US Insights Director - Respiratory Biologics · Global/US Insights, Analytics & Forecasting, Inhaled Airsupra

Tue, 28 Apr 2026 15:07:56 GMT
Engineering|Sales|Marketing|Finance|Operations|HR|IT|Design|Manufacturing|Legal|Other

Global/US Insights, Analytics & Forecasting, Inhaled Airsupra · Wilmington, Delaware, United States of America · $194,500-$291,800 · onsite

Join the Biopharmaceuticals Business Unit at AstraZeneca as a US Tozorakimab (Respiratory Biologics) Insight Director. This role is based in our US Respiratory Insight, Analytics, and Forecasting team and will lead the generation of insight and analytics in the Respiratory Biologics space for a therapy currently with multiple ongoing Phase 3 clinical trials.

This role provides strategic business insight capabilities, will have an in-depth understanding of the brand/therapeutic area and will consolidate insights from primary market research, analytics, competitive intelligence, and forecasting into insights and recommendations. As a consultative partner to the Brand teams, this role will bring independent and strategic thinking to the brand, supporting and challenging where appropriate.

The role will also require business partnership with multiple collaborators beyond the Brand team including Sales Force Operations, Finance, Market Access, and Global.

Main Responsibilities:

Partner with Brand team to develop brand strategies using a range of analytics and insight from the marketplace and provide actionable insights to inform product positioning, messaging, segmentation, demand estimation, and go-to-market strategy

Guide the performance analytics and insight involved in the development of several elements of the marketing mix: personal selling materials, direct to consumer, non-personal promotion tactics, etc.

Drive the insight and analytic plan with foresight-developing capabilities and analytics anticipating business need and the lifecycle of the portfolio

Lead the generation of competitive analysis (external analyst reports, alerts, company reports, QBR etc) for a brand, ensuring implications are reflected in the brand strategy and forecast and landed in the brand team

Accountable for the guidance and alignment of the product/brand forecast and related assumptions collaborating closely with Forecasting and Analytics colleagues

Collaborate with cross-functional teams (e.g., marketing, CI, market access) to ensure alignment on generation of insights and development of commercial strategy

Present insights and recommendations to senior leadership to guide business decisions

Design the insight plan in conjunction with the Sr. Director of Insight in order to ensure resources (dollars and people) are best leveraged to meet the true business needs

Essential requirements:

Science or commercial related 4-year degree

Experience in conducting qualitative and quantitative market research across different stakeholder groups (e.g. HCPs, patients and payers)

5+ years experience in the pharmaceutical industry

Proven ability to conduct analytics using secondary data sources key to the pharmaceutical industry (IQVIA, Prognos, Decision Resources, patient level data) and performance tracking

Good business acumen, strategic thinking and understanding of sales and marketing business practices

Ability to influence laterally and vertically

High emotional intelligence

Ability to lead projects

Ability to manage multiple tasks/assignments to demanding deadlines with minimal supervision

Strong interpersonal and collaboration skills as well as teamwork abilities

Comfortable working in a matrix environment

Strong written and verbal communication

Experience in leading insight for a specialty product with knowledge of specialty pharmacy and buy and bill distribution and tracking

Experience within specialty biologics, respiratory, or immunology therapy area

Desirable:

High degree of creativity and innovation in developing new approaches, processes and methodologies

Experience conducting pre-product launch market research (e.g., positioning, segmentation)

In-depth knowledge of respiratory biologics market dynamics